This Fact Sheet breaks down the complexities of global clinical trial supply regulations, providing actionable insights to help CTS professionals mitigate risks, ensure compliance, and build resilient, patient-centric supply chains and includes expert insights from Kamal Amin, Head of Supply Management, Galderma and Steven Jacobs, President, Global BioPharm Solutions, LLC.
Download to learn more about:
- Regulatory Updates & Compliance: Understanding the latest changes in GDP, GMP, EU CTR, ICH E6 (R3), MDR, post-Brexit UK regulations, and FDA guidelines.
- Risk Mitigation Strategies: Identify potential regulatory risks and implement proactive compliance measures.
- Supply Chain Resilience: Developing strategies to enhance flexibility and stability in an evolving regulatory environment.
- Sustainability in Clinical Supply: Exploring global initiatives to integrate sustainability into supply chain operations.
- Patient-Centric Supply Chains: Ensuring timely and compliant delivery of trial materials to improve patient outcomes.